Walter N. Hittelman

Department of Experimental Therapeutics, University of Texas MD Anderson Cancer Center

Affiliated withUniversity of Texas MD Anderson Cancer Center University of Texas MD Anderson Cancer Center

Research Area

Biography

Walter N. Hittelman has not added Biography.
If you are Walter N. Hittelman and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 6	2017

Other Publications

Article	Year
Genetic instability in epithelial tissues at risk for cancer. Annals of the New York Academy of Sciences\| PubMed ID: 11795428	2001
Biologic correlates of a biochemoprevention trial in advanced upper aerodigestive tract premalignant lesions. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology\| PubMed ID: 12496051	2002
Paclitaxel induces inactivation of p70 S6 kinase and phosphorylation of Thr421 and Ser424 via multiple signaling pathways in mitosis. Oncogene\| PubMed ID: 12555062	2003
Improvement and application of fluorescence inter-simple sequence repeat polymerase chain reaction for the study of subclonal growths in lung epithelial cell populations. Chest\| PubMed ID: 15136450	2004
Disruption of the Rad9/Rad1/Hus1 (9-1-1) complex leads to checkpoint signaling and replication defects. Oncogene\| PubMed ID: 15184880	2004
Deficiency of cell cycle checkpoints and DNA repair system predispose individuals to esophageal cancer. Mutation research\| PubMed ID: 17011594	2006
Proliferative changes in the bronchial epithelium of former smokers treated with retinoids. Journal of the National Cancer Institute\| PubMed ID: 17971525	2007
Characterization and mechanistic studies of a novel melanoma-targeting construct containing IÎºBa for specific inhibition of nuclear factor-ÎºB activity. Neoplasia (New York, N.Y.)\| PubMed ID: 20927315	2010
Are cancer stem cells radioresistant? Future oncology (London, England)\| PubMed ID: 21062156	2010
Prevention of bronchial hyperplasia by EGFR pathway inhibitors in an organotypic culture model. Cancer prevention research (Philadelphia, Pa.)\| PubMed ID: 21505178	2011
Development and characterization of a potent immunoconjugate targeting the Fn14 receptor on solid tumor cells. Molecular cancer therapeutics\| PubMed ID: 21586630	2011
Prevention of paclitaxel-induced neuropathy through activation of the central cannabinoid type 2 receptor system. Anesthesia and analgesia\| PubMed ID: 22392969	2012
Programming in situ immunofluorescence intensities through interchangeable reactions of dynamic DNA complexes. Chembiochem : a European journal of chemical biology\| PubMed ID: 23165916	2012
Construction and characterization of novel, completely human serine protease therapeutics targeting Her2/neu. Molecular cancer therapeutics\| PubMed ID: 23493312	2013
Antitumor activity of a humanized, bivalent immunotoxin targeting fn14-positive solid tumors. Cancer research\| PubMed ID: 23722548	2013
The functionalized human serine protease granzyme B/VEGF₁₂₁ targets tumor vasculature and ablates tumor growth. Molecular cancer therapeutics\| PubMed ID: 23858102	2013
Antagonism of tumoral prolactin receptor promotes autophagy-related cell death. Cell reports\| PubMed ID: 24703838	2014
MOF phosphorylation by ATM regulates 53BP1-mediated double-strand break repair pathway choice. Cell reports\| PubMed ID: 24953651	2014
Pannexin-1 Up-regulation in the Dorsal Root Ganglion Contributes to Neuropathic Pain Development. The Journal of biological chemistry\| PubMed ID: 25925949	2015
Chloride Homeostasis Critically Regulates Synaptic NMDA Receptor Activity in Neuropathic Pain. Cell reports\| PubMed ID: 27160909	2016
Cell Cycle-Dependent Mechanisms Underlie Vincristine-Induced Death of Primary Acute Lymphoblastic Leukemia Cells. Cancer research\| PubMed ID: 27197148	2016
Replication Stress Leading to Apoptosis within the S-phase Contributes to Synergism between Vorinostat and AZD1775 in HNSCC Harboring High-Risk TP53 Mutation. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 28790110	2017
Differentiation of Human Induced Pluripotent or Embryonic Stem Cells Decreases the DNA Damage Repair by Homologous Recombination. Stem cell reports\| PubMed ID: 29103969	2017